Pressure BioSciences, Inc Stock News

Pressure BioSciences, Inc. (PBIO) Acquisition of Uncle Bud's Conference Call (Transcript)

Pressure BioSciences, Inc. (PBIO) Q4 2022 Earnings Call Transcript

Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I'm just going to stic

Company Shifts Primary Business Focus to Revolutionary UST Platform. Expects to Enter FY 2023 with Ten or More Tolling Contracts.

Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am PDT SOUTH EASTON, MA / ACCESSWIRE / May 3, 2022 / Pressure BioSc

Photo by Kindel Media from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. A recent press release by Pressure BioSciences Inc. (OTCQB: PBIO ) announcing a development in its cannabidiol (CBD) research program seems to have given industry watchers an indication of the company’s future. Pressure BioSciences, a player in the development and sale of broadly enabling, pressure-based systems with applications across multiple industries, including nutraceuticals, pharmaceuticals, and biotechnology, has set its sights on being a dominant force in many of these industries. A recent expansion drive appears to support this intention. A New CBD Manufacturing Technology? Pressure BioSciences Inc. (PBI) revealed in a press release that hemp-derived CBD processed with its patented Ultra Shear Technology™ (UST™) platform produced high-quality, water-soluble nanoemulsions of CBD oil in water. The technology has now demonstrated visual and analytical stability 18 months after production and baseline testing.

PALM BEACH, Fla. , Jan. 27, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Nanoemulsion companies are adopting innovative techniques, which enhance the taste of food. Growing use of nanoemulsion in the food & beverages industry, and rising trend of nanostructured food ingredients and additive in food & beverages fuel the growth of the global nanoemulsion market… with nano technology expanding its trend in various industries, a number of opportunities have been formed for the key players in the industry. A report from Allied Market Research projected that the global nanoemulsion industry was estimated at $2.08 billion in 2018 and is expected to reach $4.91 billion by 2026, growing at a CAGR of 11.5% from 2019 to 2026… and will generate $12.4 Billion by 2027. The report said: "In the recent years, an exponential increase has been witnessed in the global population, which has propelled the food requirement. This in turn is expected to boost the need for new types of emulsifiers in the food industry.

UST Platform''s Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets South Easton, MA, December 22, 2021 Pressure BioSciences, Inc. (OTCQB: PBIO ) (PBI or the Company), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and innovative services to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, agrochemical, and food & beverage industries, today announced that hemp-derived cannabidiol (CBD) processed with its patented Ultra Shear Technology (UST) platform produced high-quality water-soluble nanoemulsions of CBD oil in water that have now demonstrated rock-solid visual and analytical stability 18 months after production and baseline testing. CBD is a widely popular therapeutic for relief of anxiety, depression, and PTSD, as well as chronic inflammatory and neuropathic pain . It is FDA-approved for use in the control of epileptic seizures in Lennox-Gastaut syndrome and Dravet syndrome .

UST Platform''s Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major MarketsSOUTH EASTON, MA / ACCESSWIRE / December 22, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("

(PR-inside.com) UST Platform''s Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets SOUTH EASTON, MA / ACCESSWIRE / December 22, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and innovative services to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, agrochemical, and food & beverage industries, today announced that hemp-derived cannabidiol ("CBD") processed with its patented Ultra Shear Technology ("UST") platform produced high-quality water-soluble nanoemulsions of CBD oil in water that have now demonstrated rock-solid visual and analytical stability 18 months after production and baseline testing. CBD ..

Pressure BioSciences, Inc. (OTCMKTS:PBIO)s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.54 and traded as low as $2.30. Pressure BioSciences shares last traded at $2.30, with a volume of 4,363 shares changing hands. The businesss 50-day moving average is $2.43 and []

Shares of Pressure BioSciences, Inc. (OTCMKTS:PBIO) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.48 and traded as low as $2.46. Pressure BioSciences shares last traded at $2.55, with a volume of 8,650 shares trading hands. The company has a market capitalization of $18.85 []

Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA / A

Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA / A

Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences SOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or